When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CMXHF - UniQure out-licenses hemophilia B gene therapy in deal valued up to ~$2.1B
Csl Ltd
UniQure (NASDAQ:QURE) inks an agreement with CSL Limited (OTCPK:CMXHF) unit CSL Behring granting the latter global rights to gene therapy etranacogene dezaparvovec for the treatment of hemophilia B.
More news on: uniQure N.V., CSL Limited, CSL Limited, Healthcare stocks news, Stocks on the move,